Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Geriatric Medicine
At what age and how often do you screen for osteoporosis in non-ambulatory (e.g. developmentally disabled) young adults without other risk factors?
Related Questions
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
Would you use a parathyroid hormone analog for treatment of osteoporosis in a patient with mildly elevated AlkPhos of unclear etiology?
Would you start romosozumab in an active smoker?
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
Do you routinely prescribe vitamin D to reduce the risk of fall-related fractures in elderly patients regardless of their serum levels?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
How long after a successful parathyroid surgery would you reassess bone density in a patient with severe osteoporosis ?
Is the FRAX score reliable in assessing fracture risk for patients with history of prior bisphosphonate use?
In adults ≥80 years with TSH 6–10 mIU/L and minimal symptoms, do you initiate levothyroxine, monitor, or avoid treatment entirely?
